Evolution of pregnancy planning in hyperprolactinemia
Open Access
- 17 June 2024
- journal article
- Published by Endocrinology Research Centre in Obesity and metabolism
- Vol. 21 (2) , 188-194
Abstract
Hyperprolactinemia has multiple etiologies and is the most common endocrine manifestation of pathology of the hypothalamic-pituitary axis. Hyperprolactinemic hypogonadism is of great scientific interest due to the prevalence of endocrine pathology in the reproductive period and its effect on metabolic processes. Hyperprolactinemia is one of the serious obstacles to the implementation of reproductive function in both women and men. The article discusses current issues of diagnosis and management tactics for patients with hyperprolactinemia of various etiologies within the framework of preconception preparation.Keywords
This publication has 51 references indexed in Scilit:
- Impact of Endocrine Disorders on IVF Outcomes: Results from a Large, Single-Centre, Prospective StudyReproductive Sciences, 2022
- Prolactin immunoassay: does the high-dose hook effect still exist?Pituitary, 2022
- Prolactinomas in pregnancy: considerations before conception and during pregnancyPituitary, 2019
- A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomasPituitary, 2019
- Pituitary Tumors in PregnancyEndocrinology and Metabolism Clinics of North America, 2019
- Prevalence and reproductive manifestations of macroprolactinemiaEndocrine, 2018
- Cabergoline versus bromocriptine for the treatment of giant prolactinomas: A quantitative and systematic reviewMetabolic Brain Disease, 2018
- Pregnancy outcome in women exposed to dopamine agonists during pregnancy: a pharmacoepidemiology study in EFEMERIS databaseArchives of Gynecology and Obstetrics, 2014
- Macroprolactinemia in hyperprolactinemic infertile womenEndocrine, 2013
- Autoantibody Profile in the Sera of Women with HyperprolactinemiaJournal of Autoimmunity, 1995